Pharmaceutical

Large European study underlines power of genomic sequen...

A new study further validates the power of genome sequencing to pinpoint the roo...

STAT+: Senate hashing out policy details on generics, P...

Senators are slightly delaying their latest legislative push on health care, but...

Juul agrees to pay $462 million to 6 states and D.C., a...

The $462 million settlement will also require Juul to disclose a number of previ...

China accepts Junshi’s new drug application for NSCLC c...

Interim analysis of the Neotorch trial revealed that the combo therapy could not...

US FDA approves Takeda’s HyQvia to treat PI in children

The FDA approval was based on the data obtained from an open-label, pivotal Phas...

Recent court ruling may affect colorectal cancer and HI...

With lower screening rates, many of these cancers will probably be detected at a...

Novo Nordisk and Aspect join forces for bioprinting tis...

Novo Nordisk and Aspect enter a multimillion dollar partnership to produce pancr...

BMS’s repotrectinib to have FoundationOne genomic seque...

Foundation Medicine’s tissue-based test will be a companion diagnostic to BMS’s ...

Panbela obtains rights to develop and commercialise Fly...

Panbela will lead on the design of the global trial protocol.

LyGenesis and Imagine Pharma partner for type 1 diabete...

The collaboration will leverage LyGenesis’s allogeneic cell therapy platform and...

Xenetic Biosciences forms research collaboration with TSRI

The collaboration will advance the development of Xenetic’s systemic DNase progr...

Primate models in pharma: What the future holds

Federal agencies in the US, Europe, and elsewhere are regulating the use of prim...

Pharming undertakes Joenja’s first shipments to APDS pa...

Pharming has made a $10m milestone payment to Novartis for the first commercial ...

STAT+: Just how big a pay bump do hospitals need from M...

Just how big of a pay bump do hospitals need from Medicare next year? The federa...

STAT+: How many? One-third of late-stage trials testing...

"It's critical patients and doctors have access to results to ascertain benefits...

STAT+: Oracle’s Cerner Enviza launches a new effort to ...

Oracle has launched a new effort that will use AI to make use of the trove of da...